From cancer models, the regulation of EZH2 expression and function is more fully elucidated and how its modulation in both CD4+ and CD8+ T cells can, directly and indirectly, impact the CD8+ T cells response (Figure 3). The gene discussed is CD8A; the disease is cancer.